<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Polyamines predicts Poor prognosis in female Colorectal Cancer patients — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Polyamines</strong>
  <span class="pred">&mdash;predicts&rarr;</span>
  <strong>Poor prognosis in female Colorectal Cancer patients</strong>
</div>
<div class="entity-id">UNKNOWN:polyamines &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 4.50<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 8 &rarr; score 4.50</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.3390/metabo12020164">10.3390/metabo12020164</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1122">MTBLS1122</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 8 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:60px"></span><span>3</span><span class="cite-subtotal">&middot; +1.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — decreases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5b9fd8385eebefbc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — is_metabolite_of → Dopamine</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9d15c51242cd4d8a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PD-L1 — decreases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/992b53bb0ac0d604.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>5</span><span class="cite-subtotal">&middot; +3.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Homovanillic acid — distinguishes → Early-onset colorectal cancer vs Late-onset colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0f531ae42a1d7ef1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phospholipid signaling — increases → Early-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4c5bc2efcf6318a3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">EGFR signaling — increases → Late-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.60</span><a href="../claim/aa2e129fdb6224e0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Oxidative stress-related genes — increases → Late-onset colorectal cancer tumor tissue</span><span class="cite-claim-weight">+0.60</span><a href="../claim/e4c557304ecfb2da.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Tumor metabolome alterations (155 metabolites) — distinguishes → Colorectal cancer tumor vs normal tissue</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6e9d53e11b9bcf11.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>6dc001440b4efbb6</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:polyamines">UNKNOWN:polyamines</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
